Apollon Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $703K | Sell |
|
|||||
|
2025
Q2 | $781K | Buy |
|
|||||
|
2025
Q1 | $574K | Buy |
|
|||||
|
2024
Q4 | $538K | Sell |
|
|||||
|
2024
Q3 | $558K | Sell |
|
|||||
|
2024
Q2 | $1.18M | Sell |
|
|||||
|
2024
Q1 | $2.03M | Buy |
|
|||||
|
2023
Q4 | $1.61M | Buy |
|
|||||
|
2023
Q3 | $1.21M | Sell |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $1.03M | Buy |
|
|||||
|
2022
Q4 | $923K | Buy |
|
|||||
|
2022
Q3 | $984K | Buy |
|
|||||
|
2022
Q2 | $1.13M | Buy |
|
|||||
|
2022
Q1 | $1.29M | Buy |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $242K | Buy |
|
|||||
|
2021
Q2 | $217K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $39K | Buy |
|